Your browser doesn't support javascript.
loading
Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody.
Mittler, Eva; Serris, Alexandra; Esterman, Emma S; Florez, Catalina; Polanco, Laura C; O'Brien, Cecilia M; Slough, Megan M; Tynell, Janne; Gröning, Remigius; Sun, Yan; Abelson, Dafna M; Wec, Anna Z; Haslwanter, Denise; Keller, Markus; Ye, Chunyan; Bakken, Russel R; Jangra, Rohit K; Dye, John M; Ahlm, Clas; Rappazzo, C Garrett; Ulrich, Rainer G; Zeitlin, Larry; Geoghegan, James C; Bradfute, Steven B; Sidoli, Simone; Forsell, Mattias N E; Strandin, Tomas; Rey, Felix A; Herbert, Andrew S; Walker, Laura M; Chandran, Kartik; Guardado-Calvo, Pablo.
Afiliação
  • Mittler E; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Serris A; Institut Pasteur, Université Paris Cité, CNRS UMR3569, Structural Virology Unit, F-75015 Paris, France.
  • Esterman ES; Adimab LLC, Lebanon, NH 03766, USA.
  • Florez C; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA.
  • Polanco LC; The Geneva Foundation, Tacoma, WA 98402, USA.
  • O'Brien CM; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Slough MM; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA.
  • Tynell J; The Geneva Foundation, Tacoma, WA 98402, USA.
  • Gröning R; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Sun Y; Department of Clinical Microbiology, Umeå University, 90187 Umeå, Sweden.
  • Abelson DM; Zoonosis Unit, Department of Virology, Medical Faculty, University of Helsinki, 00290 Helsinki, Finland.
  • Wec AZ; Department of Clinical Microbiology, Umeå University, 90187 Umeå, Sweden.
  • Haslwanter D; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Keller M; Mapp Biopharmaceutical Inc., San Diego, CA 92121, USA.
  • Ye C; Adimab LLC, Lebanon, NH 03766, USA.
  • Bakken RR; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Jangra RK; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 17493 Greifswald-Insel Riems, Germany.
  • Dye JM; Center for Global Health, Department of Internal Medicine, University of New Mexico Health Science Center, Albuquerque, NM 87131, USA.
  • Ahlm C; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA.
  • Rappazzo CG; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Ulrich RG; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA.
  • Zeitlin L; Department of Clinical Microbiology, Umeå University, 90187 Umeå, Sweden.
  • Geoghegan JC; Adimab LLC, Lebanon, NH 03766, USA.
  • Bradfute SB; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 17493 Greifswald-Insel Riems, Germany.
  • Sidoli S; Partner site: Hamburg-Lübeck-Borstel-Riems, German Centre for Infection Research (DZIF), 17493 Greifswald-Insel Riems, Germany.
  • Forsell MNE; Mapp Biopharmaceutical Inc., San Diego, CA 92121, USA.
  • Strandin T; Adimab LLC, Lebanon, NH 03766, USA.
  • Rey FA; Center for Global Health, Department of Internal Medicine, University of New Mexico Health Science Center, Albuquerque, NM 87131, USA.
  • Herbert AS; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Walker LM; Department of Clinical Microbiology, Umeå University, 90187 Umeå, Sweden.
  • Chandran K; Zoonosis Unit, Department of Virology, Medical Faculty, University of Helsinki, 00290 Helsinki, Finland.
  • Guardado-Calvo P; Institut Pasteur, Université Paris Cité, CNRS UMR3569, Structural Virology Unit, F-75015 Paris, France.
Sci Transl Med ; 15(700): eadg1855, 2023 06 14.
Article em En | MEDLINE | ID: mdl-37315110
ABSTRACT
Emerging rodent-borne hantaviruses cause severe diseases in humans with no approved vaccines or therapeutics. We recently isolated a monoclonal broadly neutralizing antibody (nAb) from a Puumala virus-experienced human donor. Here, we report its structure bound to its target, the Gn/Gc glycoprotein heterodimer comprising the viral fusion complex. The structure explains the broad activity of the nAb It recognizes conserved Gc fusion loop sequences and the main chain of variable Gn sequences, thereby straddling the Gn/Gc heterodimer and locking it in its prefusion conformation. We show that the nAb's accelerated dissociation from the divergent Andes virus Gn/Gc at endosomal acidic pH limits its potency against this highly lethal virus and correct this liability by engineering an optimized variant that sets a benchmark as a candidate pan-hantavirus therapeutic.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Orthohantavírus / Anticorpos Antivirais Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Orthohantavírus / Anticorpos Antivirais Idioma: En Ano de publicação: 2023 Tipo de documento: Article